November 6, 2013in Access to Medicines, Canada, Cross Border Issues, European Union, IP, IP Reform, Jurisdiction, Patents, Pharmaceutical Drugs, Uncategorized0by Editor1262 CETA: A Very Reasonable Canadian-esque Compromise on Pharmaceutical Intellectual Property Law Changes At long last, the Canadian Federal Government and the European Commission announced in October that a political agreement has been reached regarding the much anticipated Comprehensive Economic and Trade Agreement…
